Skip to main content
Home
Publications
Podiatry Today
Today's Wound Clinic
Wound Management & Prevention
Wounds
Events
Educations
About
email
Contact
search
Search
Go
account_circle
Sign in
Main navigation
Education
WoundCon
Webinars
White Papers
Continuing Education
MATE Act Training
Industry News
Practice Accelerator
Clinical Insights
About
About WoundSource
Editorial Advisory Board
Guidelines for Contributors
Video Demo Center
CTP Reimbursement
Breadcrumb
CTP Reimbursement
How Much Do You Know About Reimbursement?
How Much Do You Know About Reimbursement?
<section><h2>How Much Do You Know About Reimbursement?</h2></section><section><h2><h2><p>As of December 2023, which of the following place of service codes best reflects a service performed via telehealth to a patient&rsquo;s home?</p></h2></h2></section><section><h3><h2><p>TRUE or FALSE: As of December 2023, reimbursement is always the same and fully applicable for cellular- and tissue-based product application in every place of service.</p></h2></h3></section><section><h3><h2><p>In health care billing and coding, &ldquo;ICD-10&rdquo; code stands for which of the following?</p></h2></h3></section><section><h3><h2><p><strong></strong>As of December 2023, which of the below is the modifier that will indicate how much of a cellular- and tissue-based product is not used, or is wasted?</p></h2></h3></section><section><h3><h2><p>What is the name of the Centers for Medicare and Medicaid Services (CMS) document, specific to one&rsquo;s region, that outlines current details of coverage of products and services, including requirements, applicable codes, and other information?</p></h2></h3></section><section><h3><h2><p>Although Medicare is a national program in the United States, what is the name used for the entities that administer the Medicare program on a local level?</p></h2></h3></section><section><h3><h2><p>At the time of publication, according to Chapter 13 of the Medicare Program Integrity Manual (13.5.4), which of the following is NOT a parameter for a service to be deemed &ldquo;reasonable and necessary&rdquo;?</p></h2></h3></section><section><h3><h2><p>Which of the following is TRUE about appropriate documentation of the use of a cellular- and tissue-based product (CTP)?</p></h2></h3></section><section><h3><h2><p>TRUE or FALSE? Some payors have policies that require compliant use of compression therapy for a predetermined time period before allowing coverage for CTP application for a venous leg ulcer.</p></h2></h3></section><section><h3><h2><p>Which of the following is TRUE regarding documentation of repeated CTP applications?</p></h2></h3></section><section><h2></h2></section><section><h3></h3></section>
